[462] Utility of Repeat Thyroid FNA in the Management of Patients with Thyroid Nodules
RS Singh, JL Hecht, HH Wang. Beth Israel Deaconess Medical Center, Boston, MA
Background: In the new Bethesda System for reporting thyroid FNA, repeat FNA is recommended for an initial diagnosis of non-diagnostic or atypical cells/follicular lesion of undetermined significance. We therefore investigated the pattern of repeat thyroid FNA at our institution.
Design: We retrospectively reviewed all reports on thyroid FNAs and thyroidectomies submitted to the pathology department from 2006 to 2008 at our institution. All patients who had a repeated FNA of the same lesion and all who had both FNA and thyroidectomy in the same time period were identified.
Results: 2,717 FNA specimens were identified. 608 had thyroidectomies during the same time period. 291 patients underwent repeated FNA at least once for 301 thyroid lesions. Thirty had a second repeat and one had a third repeat. The main findings are listed below. (ND=non-diagnostic; Sub=suboptimal; B=benign; F=follicular lesion with or without cystic change that cannot be further categorized due to cellularity; MF=microfollicular; H=Hurthle cell; P=papillary carcinoma; Ind=indeterminate for malignancy that includes MF, H, or suggestive but not diagnostic for P; Sus=suspicious for malignancy; Pos=positive for malignancy).
| Diagnostic category | Initial aspirates (%)* | Number (%) with at least one repeat | Diagnosis of first repeat (%)* | Diagnosis of second repeat (%)* | % of patients with surgery after initial diagnosis** |
| ND | 316 (13) | 132 (42) | 53 (18) | 4 (13) | 9.2 |
| Sub -B or F | 495 (21) | 81 (16) | 61 (20) | 12 (40) | 13 |
| Sub -MF+H+P | 84 (3.5) | 27 (32) | 19 (6.3) | 1 (3.3) | 40 |
| B | 980 (41) | 28 (2.9) | 124 (41) | 12 (40) | 6.8 |
| Atypical | 89 (3.7) | 21 (24) | 11 (3.7) | 1 (3.3) | 49 |
| Ind | 216 (9.1) | 11 (5.1) | 20 (6.6) | 0 | 73 |
| Sus+Pos | 205 (8.6) | 1 (0.49) | 13 (4.3) | 0 | 69 |
| Total | 2385 | 301 (13) | 301 | 30 | 23 |